Free Trial

Cabot (CBT) Competitors

Cabot logo
$81.28 -0.67 (-0.82%)
As of 12:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CBT vs. ASIX, AVNT, CC, EMN, FUL, LYB, NTR, OEC, OLN, and WLK

Should you be buying Cabot stock or one of its competitors? The main competitors of Cabot include AdvanSix (ASIX), Avient (AVNT), Chemours (CC), Eastman Chemical (EMN), H. B. Fuller (FUL), LyondellBasell Industries (LYB), Nutrien (NTR), Orion (OEC), Olin (OLN), and Westlake (WLK). These companies are all part of the "basic materials" sector.

Cabot vs. Its Competitors

Cabot (NYSE:CBT) and AdvanSix (NYSE:ASIX) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

In the previous week, Cabot had 7 more articles in the media than AdvanSix. MarketBeat recorded 12 mentions for Cabot and 5 mentions for AdvanSix. AdvanSix's average media sentiment score of 1.69 beat Cabot's score of 1.64 indicating that AdvanSix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cabot
12 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
AdvanSix
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

93.2% of Cabot shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 3.0% of Cabot shares are owned by insiders. Comparatively, 5.6% of AdvanSix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.1%. Cabot pays out 23.5% of its earnings in the form of a dividend. AdvanSix pays out 22.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years and AdvanSix has increased its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and lower payout ratio.

Cabot has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500.

Cabot presently has a consensus price target of $92.33, suggesting a potential upside of 13.60%. AdvanSix has a consensus price target of $33.50, suggesting a potential upside of 60.73%. Given AdvanSix's stronger consensus rating and higher possible upside, analysts plainly believe AdvanSix is more favorable than Cabot.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cabot
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
AdvanSix
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Cabot has a net margin of 11.14% compared to AdvanSix's net margin of 5.10%. Cabot's return on equity of 25.68% beat AdvanSix's return on equity.

Company Net Margins Return on Equity Return on Assets
Cabot11.14% 25.68% 10.92%
AdvanSix 5.10%10.02%4.97%

Cabot has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cabot$3.99B1.08$380M$7.6510.62
AdvanSix$1.52B0.37$44.15M$2.847.34

Summary

Cabot beats AdvanSix on 11 of the 18 factors compared between the two stocks.

Get Cabot News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CBT vs. The Competition

MetricCabotCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$4.32B$11.81B$3.43B$21.26B
Dividend Yield2.21%3.31%5.13%3.53%
P/E Ratio10.6227.16112.7829.24
Price / Sales1.086.7533,708,491,670,826,400.0053.45
Price / Cash8.137.5724.1723.64
Price / Book2.572.346.175.37
Net Income$380M$508.39M$150.51M$996.59M
7 Day Performance2.77%2.55%3.20%2.96%
1 Month Performance7.96%0.60%5.61%2.83%
1 Year Performance-21.19%0.91%38.46%12.71%

Cabot Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CBT
Cabot
4.6458 of 5 stars
$81.28
-0.8%
$92.33
+13.6%
-20.7%$4.32B$3.99B10.624,200Positive News
ASIX
AdvanSix
4.2436 of 5 stars
$20.10
+3.4%
$33.50
+66.7%
-30.3%$539.48M$1.52B7.081,450News Coverage
AVNT
Avient
4.2919 of 5 stars
$35.80
+1.0%
$45.60
+27.4%
-22.5%$3.28B$3.24B27.979,200Positive News
CC
Chemours
3.6596 of 5 stars
$14.92
+2.1%
$17.38
+16.5%
-21.2%$2.23B$5.78B-5.336,000Positive News
EMN
Eastman Chemical
4.9443 of 5 stars
$65.80
+0.4%
$87.00
+32.2%
-31.5%$7.56B$9.38B9.2414,000Positive News
FUL
H. B. Fuller
4.1423 of 5 stars
$58.99
+0.0%
$67.25
+14.0%
-25.7%$3.18B$3.57B31.897,500Positive News
LYB
LyondellBasell Industries
4.8188 of 5 stars
$53.01
-0.7%
$63.08
+19.0%
-42.3%$17.05B$40.30B68.8520,000Positive News
Ex-Dividend
NTR
Nutrien
4.3877 of 5 stars
$56.70
-0.8%
$62.65
+10.5%
+20.2%$27.61B$25.97B20.3225,500Positive News
OEC
Orion
3.6936 of 5 stars
$10.07
flat
$12.00
+19.2%
-42.8%$565.43M$1.88B37.301,658Positive News
OLN
Olin
4.068 of 5 stars
$21.30
0.0%
$25.57
+20.1%
-47.3%$2.44B$6.54B-177.467,676Positive News
WLK
Westlake
3.4604 of 5 stars
$83.45
-0.6%
$92.29
+10.6%
-40.7%$10.70B$12.14B-157.4415,540Positive News
Analyst Revision

Related Companies and Tools


This page (NYSE:CBT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners